Table 2 Tolerance to house dust mite SLIT during treatment
Patients with at least one follow-up visit | (n = 278) |
|---|---|
Patients with at least one adverse event reported during a follow-up visit* | |
No | 226 (82.2%) |
Yes | 49 (17.8%) |
If yes** | |
At least one local reaction reported | 41 (89.1%) |
At least one systemic reaction reported | 7 (15.2%) |
At least one other reaction reported# | 1 (2.2%) |